TFGT
UBX

TS Financial Group (TSFG)’s Unity Biotechnology UBX Stock Holding History

TS Financial Group (TSFG)’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50
Closed -$1K – 1040
2023
Q3 		$1K Hold
50
– – ﹤0.01% 1014
2023
Q2 		$0 Hold
50
– – ﹤0.01% 1062
2023
Q1 		$0 Hold
50
– – ﹤0.01% 1011
2022
Q4 		$0 Hold
50
– – ﹤0.01% 1023
2022
Q3 		$0 Hold
50
– – ﹤0.01% 1037
2022
Q2 		$0 Hold
50
– – ﹤0.01% 1064
2022
Q1 		$1K Hold
50
– – ﹤0.01% 894
2021
Q4 		$1K Buy
+50
New +$1.09K ﹤0.01% 865

Other funds holding UBX

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

TS Financial Group (TSFG)'s UBX Position: Q4 2023 in Review

TS Financial Group (TSFG) sold out of Unity Biotechnology (UBX) in Q4 2023, closing a stake of 50 shares — an estimated $1K sold.

TS Financial Group (TSFG) first reported a position in UBX in Q4 2021 and held it in 8 quarters. The position peaked at $1K in Q3 2023. 42 funds tracked by Wall St. Rank hold UBX as of Q4 2023.

  • TS Financial Group (TSFG) reported no remaining Unity Biotechnology position as of Q4 2023 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 50 Unity Biotechnology shares in Q4 2023, an estimated $1K.
  • TS Financial Group (TSFG) first reported a position in Unity Biotechnology in Q4 2021 and held it in 8 quarters.
  • TS Financial Group (TSFG)'s Unity Biotechnology position peaked at $1K in Q3 2023.
  • 42 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2023.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2023, filed 24 Jan 2024.